Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion type Assertion NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_head.
- NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion description "[CD56-positive T-lineage PC-ENKTL tumors (n=8) had more localized disease in the TNM (tumor-node-metastasis) staging and were more often of ?? T-cell origin compared with cases of PC-CD56+PTCL (n=9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_provenance.
- NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion evidence source_evidence_literature NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_provenance.
- NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion SIO_000772 25188863 NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_provenance.
- NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion wasDerivedFrom befree-20150227 NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_provenance.
- NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_assertion wasGeneratedBy ECO_0000203 NP585463.RA41_DcgZh1l-uJZaIs2Vs2UZjus-J27Y4QAvK1c8dqY0130_provenance.